U.S. manufacturer of sanitizing and germicidal cleaning solutions Durisan announces the appointment of Naji N. Abumrad, MD, FACS, to its Scientific Advisory Board. Dr. Abumrad is the John L. Sawyers Professor of Surgery and Executive Medical Director of the Surgery Patient Care Center at Vanderbilt Medical Center in Nashville, Tenn.
Dr. Abumrad is the inaugural member and Chairman of the newly established Scientific Advisory Board. His charge includes identifying potential board members with the knowledge and experience to help Durisan conduct research and with product development, as well as informing organizational investment and expansion into markets.
Dr. Abumrad’s clinical interests cover all aspects of general surgery and, particularly, endocrine surgery. His extensive research includes studies of the mechanism of insulin resistance in the morbidly obese and studies relating to the understanding of the mechanisms involved in the reversal of type 2 diabetes in morbidly obese patients who undergo bariatric surgery. Additional studies address the metabolic effects of opioid peptides and opiate alkaloids, as well as cocaine, on energy metabolism and fuel mobilization. Dr. Abumrad’s work has been funded by NIH grants during most of his academic career.
Dr. Abumrad is active in numerous professional associations, including the American Surgical Association, the Society for University Surgeons, the Association of Academic Surgery, the American Diabetes Association, the Endocrine Society, the Nashville Surgical Society and the Tennessee Academy of Medicine.
As a reviewer for many professional journals, Dr. Abumrad contributes to publications such as the Journal of Clinical Investigation, Diabetes, Metabolism, Endocrinology, American Journal of Clinical Nutrition, New England Journal of Medicine, Science, Nature and Proceedings of the National Academy of Science. He has authored more than 250 articles in peer-reviewed journals and several book chapters. Some of his topics include research findings on metabolic activity and hypoglycemia, the repair of metabolic processes, the effects of metabolic responses during insulin deficiency, the hormonal and metabolic effects of neuroglycopenia and the effects of fasting on metabolism.
Durisan’s formula is manufactured in an FDA and EPA-compliant facility. The nontoxic products are safe for people and the environment, while providing effective disinfecting on hands, surfaces and textiles.
Durisan was founded in 2014 after developing a durable alcohol-free antimicrobial system for clothing that also worked astonishingly well on other surfaces. Proudly made in the USA and based in Sarasota, Fla., Durisan produces a range of sanitizing products for commercial and residential use that is people-, animal- and earth-friendly. Learn more about our products at Durisan.com.